Applications for this meeting must be submitted by July 6, 2013. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the Conference Chair if more seats become available due to cancellations.
GRS Speaker Abstract Deadline: Although applications will be accepted until the date noted above, any applicants who wish to be considered for an oral presentation should submit their application by May 3, 2013. Please refer to the Application Instructions section below for more details (if available).
The Cannabinoid Function in the CNS Gordon Research Seminar will be held in conjunction with the Cannabinoid Function in the CNS Gordon Research Conference
. Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Please refer to the Cannabinoid Function in the CNS GRC web page for more information.
The Gordon Research Seminar on Cannabinoid Function in the CNS is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
The focus of this meeting is to explore the endocannabinoid modulation of neural function in healthy and diseased states that often results in altered behavioral and clinical processes. The meeting will highlight a mentorship component and cutting edge research topics including, although not limited to, development, learning and memory, drug use and addiction, emotional and sensory processes, neurodegenerative disorders, behavioral and cognitive disorders, pain and stress-related disorders, sleep, feeding and metabolism.
The meeting will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.
The Chairs will select speakers from abstracts submitted by May 3, 2013. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate, you must submit an application by the date indicated in the Application Deadline section above.
|1:00 pm - 5:00 pm||Arrival and Check-in|
|3:30 pm - 3:45 pm||Introductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair|
|3:45 pm - 4:30 pm||Keynote Lecture|
|Discussion Leader: Valerio Chiurchiu (IRCCS Santa Lucia Foundation)|
|3:45 pm - 4:15 pm||Cecilia J. Hillard (Medical College of Wisconsin,USA)
"Endocannabinoid signaling and Homeostasis"
|4:15 pm - 4:30 pm||Discussion|
|4:30 pm - 6:00 pm||Poster Session I|
|7:30 pm - 9:30 pm||Endocannabinoid modulation of neural function|
|Discussion Leaders: Brady Atwood (NIAAA) and Keri Hildick (University of Bristol) |
|7:30 pm - 7:50 pm||JingJing Wu (The Johns Hopkins School of Medicine)
"Cannabinoid signaling in the mammalian inner ear"
|7:50 pm - 8:00 pm||Discussion|
|8:00 pm - 8:20 pm||David Kupferschmidt (NIAAA)
"Divergent roles for presynaptic calcium in plasticity of cortical inputs to the dorsolateral striatum"
|8:20 pm - 8:30 pm||Discussion|
|8:30 pm - 8:50 pm||Huikun Wang (NIDA)
"Cocaine depresses GABA(B) receptor-mediated transmission in dopamine neurons via endocannabinoid- and serotonin-dependent mechanisms"
|8:50 pm - 9:00 pm||Discussion|
|9:00 pm - 9:20 pm||Geoffrey Vargish (NICHD)
"The endocannabinoid system in peripheral blood innate immune cells as a mirror of neuroinflammatory processes of multiple sclerosis"
|9:20 pm - 9:30 pm||Discussion|
|7:30 am - 8:30 am||Breakfast|
|9:00 am - 10:00 am||Mentorship Session|
|Discussion Leaders: Jacqueline Flores-Otero (Institute of Neurology, UPR)|
|9:00 am - 9:20 am||Traci Czyzyk-Morgan (Mayo Clinic Arizona)
"Taking the road less traveled to an academic faculty position"
|9:20 am - 9:30 am||Discussion|
|9:30 am - 9:50 am||Heather B. Bradshaw (Indiana University)
"Encouraging autonomy through structure: frameworks and fun"
|9:50 am - 10:00 am||Discussion|
|10:00 am - 11:00 am||Neuropathological disorders induced disruption of the endocannabinoid system|
|Discussion Leader: Ku-Lung Hsu (Scripps Research Institute)|
|10:00 am - 10:20 am||Daniel Morgan (Penn State College of Medicine)
"Characterization of a novel JNK-mediated mechanism of cannabinoid tolerance"
|10:20 am - 10:30 am||Discussion|
|10:30 am - 10:50 am||Verginia Cuzon-Carlson (NIAAA)
"Gestational ethanol exposure decreases GABAergic inhibition in the dorsal striatum through interactions with the cannabinoid system"
|10:50 am - 11:00 am||Discussion|
|11:00 am - 12:30 pm||Poster Session II|
|Coffee will be served in the poster area from 11:00 am - 11:30 am|
|1:30 pm - 2:30 pm||Ensuing effects of endocannabinoid modulation on disruption of behavioral processes|
|Discussion Leader: Erik Oleson (Maryland University)|
|1:30 pm - 1:50 pm||Ozge Gunduz-Cinar (NIH/NIAAA)
"Anandamide modulates fear extinction via activation of calcineurin in amygdala"
|1:50 pm - 2:00 pm||Discussion|
|2:00 pm - 2:20 pm||Natalia Murataeva (Indiana University)
"CB2 cannabinoid receptor deletion does not affect cocaine-induced reward and sensitization in mice"
|2:20 pm - 2:30 pm||Discussion|
|2:30 pm - 3:00 pm||Evaluation Period|
|Fill out GRS Evaluation Forms|
|3:00 pm||Gordon Research Seminar ends. For those attending the associated Gordon Research Conference, please check in at the GRC Office beginning at 4:00 pm.|
Funding for this conference was made possible (in part) by 1 R13 DA035550-01A1 from the National Institute on Drug Abuse. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Last Updated: May 22, 2013